期刊文献+

血清乙型肝炎病毒DNA水平对HBV全基因组克隆效率的影响 被引量:3

Impact of HBV DNA level in serum on the cloning efficiency of HBV full length genome
下载PDF
导出
摘要 目的:通过比较血清HBV DNA水平对一片段PCR法和两片段PCR法这两种不同方法的HBV全基因组克隆效率的影响,选择出合适的HBV全基因组克隆技术,供后续的HBV的基础和临床研究。方法:采集了慢性乙型肝炎(CHB)患者85份血清,分别用本研究建立的一片段PCR法及两片段PCR法扩增HBV全基因组,经双酶切鉴定后将PCR产物克隆入载体,进行HBV全基因组序列测定。同时用实时荧光定量PCR法检测上述85份血清的HBV DNA滴度。结果:本研究建立的一片段PCR法扩增成功需要的血清HBV DNA浓度高于两片段PCR法,两种方法扩增的效率比较为:一片段PCR法扩增的阳性率低于两片段PCR法(P<0.01)。一片段PCR法的保真性和灵敏度分析发现:保真性:核苷酸的人为突变率为1.13bp/kb;灵敏度:为102个初始模板。浓度大于103的重组质粒DNA80%可以成功扩增,浓度低于该值的扩增效率比较低。结论:血清HBV DNA水平对两种扩增方法的阳性率有一定影响,滴度高低是选择合适PCR扩增方法的依据。HBV DNA滴度大于106copies/L的样本,可选用一片段PCR法的全基因组扩增、克隆技术,而对HBV DNA滴度小于106copies/L样本,则可选用两片段PCR法的全基因组扩增、克隆技术。本研究建立的一片段PCR法扩增HBV全基因组克隆的技术是一种值得推荐的好方法,但还需进一步优化。 AIM: To compare the cloning efficacy of full -length HBV genome amplified by single fragment PCR and two fragment PCR for choosing the suitable method for full - length HBV genome cloning. METHODS : To amplify the fttll- length HBV genome from 85 sera sample of HBV patients, single fragment PCR and two fragment PCR were conducted. The products were cloned into the vector and sequenced after identified with double enzyme digestion. At the same time, the titers of 85 samples were detected by real - time PCR. RESULTS : Compared with two fragment PCR, single fragment PCR requested higher level of sera HBV DNA for successful amplification of full - length HBV genome, and the efficacy of single fragment PCR was lower than that of two fragments PCR ( P 〈 0.05). The mutation ratio of single fragment PCR was 1.13 bp/kb, and the sensitivity of single fragment PCR was 10^2 original templates. The efficacy of amplification was 80% if the amounts of template exceed 10^3, but the efficacy was low under this value. CONCLUSION: The efficacy of amplification is affected by the level of sera HBV DNA. The titers of sera HBV DNA are the proof for choosing a suitable PCR method. If the level of sera HBV DNA was more than 10^6 copies/L, single fragment PCR will be suitable. If the level of sera HBV DNA was less than 10^6 copies/L, two fragments PCR will be better.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第7期1384-1389,共6页 Chinese Journal of Pathophysiology
基金 广东省教育厅“千百十工程”优秀人才培养基金资助项目(No.Q02034) 广东省医学科研基金资助项目(No.A2003222) 教育部新世纪优秀人才支持计划资助项目(No.NCET-04-0797) 广东省肝脏疾病研究重点实验室启动项目资助(No.2005B60148)
关键词 肝炎病毒 乙型 基因组 慢性乙型肝炎 Hepatitis B virus Genome
  • 相关文献

参考文献2

二级参考文献12

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2Qaqish RB,Mattes KA,Ritchie DJ.Adefovir dipivoxil:a new antiviral agent for the treatment of hepatitis B virus infection.Clin Ther,2003,25:3084-3099.
  • 3Hadziyannis S J,Tassopoulos NC,Heathcote E J,et al.Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.N Engl J Med,2005,352:2673-2681.
  • 4Marcellin P,Chang TT,Lim SG,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.N Engl J Med,2003,348:808-816.
  • 5Kim KM,Choi WB,Lim YS,et al.Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus.J Korean Med Sci,2005,20:821-828.
  • 6Lo CM,Liu CL,Lau GK,et al.Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.Liver Transpl,2005,11:807-813.
  • 7Gunther S,Li BC,Miska S,et al.A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients.J Virol,1995,69:5437-5444.
  • 8Gunther S,Sommer G,Von Breunig F,et al.Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia:frequency and functional consequences of PCR-introduced mutations.J Clin Microbiol,1998,36:531-538.
  • 9Khakoo SI,Ling R,Scott I,et al.Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg,anti-HBe positive individuals.Gut,2000,47:137-143.
  • 10Stuyver LJ,Locarnini SA,Lok A,et al.Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.Hepatology,2001,33:751-757.

共引文献14013

同被引文献26

  • 1刘光泽,孔祥平,任向荣,李秀梅,胡莲美,黄黎珍,顾为望.高复制HBV转基因小鼠模型对抗乙型肝炎病毒药物的效应研究[J].中国病理生理杂志,2007,23(1):99-102. 被引量:7
  • 2Brunetto MR, Moriconi F, Bonino F,et al. Hepatitis B virus surface antigen levels: a guide to sustained response to poginterferon alfa -2a in HBeAg - negative chronic hepatitis B [ J ]. Hepatology, 2009,49 (g) : 1141 - 1150.
  • 3Chen J J, Wang ZH, Guo YB, et al. Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg - interferon - α - 2a [J]. Antiviral Res, 2009, 81(1): 88-91.
  • 4Chan HL, Wong VW, Tse AM,et al. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response [ J ]. Clin Gastroenterol Hepatol, 2007,5 (12) : 1462 - 1468.
  • 5Takagi K, Tanaka Y, Naganuma H, et al. Clinical evaluation of a novel HBsAg quantitative assay [ J ]. Rinsho Byori, 2007,55(7) :619-625.
  • 6Chen CH, Lee CM, Wang JH, et al. Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers[ J]. Eur J Gastroenterol Hepatol, 2004,16( 11 ) :1213 - 1218.
  • 7Deguchi M, Yamashita N, Kagita M, et al. Quantitation of hepatitis B surface antigen by an automated ehemiluminescent microparticle immunoassay[J]. J Virol Methods, 2004,115(2) :217 -222.
  • 8Ozaras R, Tabak F, Tahan V, et al. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment[J]. Dig Dis Sci, 2008,53(11) :2995 - 2998.
  • 9Rodella A, Galli C, Teflenghi L, et al. Quantitative analysis of HBsAg, IgM anti - HBe and anti - HBe avidity in acute and chronic hepatitis B[J]. J Clin Virol, 2006,37 (3) :206 -212.
  • 10Guettouche T, Hnatyszyn HJ. Chronic hepatitis B and viral genotype: the clinical significance of determining HBV genotypes. Antivir Ther, 2005, 10: 593-604.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部